Some Specific Chromosomal Aberrations of Hematologic Malignancies in 80 Iranian Population
,
Abstract
Introduction: Most of the hematologic malignancies are heterogenous with regard to morphology, immunophenotype, and genetic rearrangements. Multiple recurrent chromosomal aberrations have been identified by conventional cytogenetic analysis, which is now widely recognized as one of the most important diagnostic and prognostic determinants in these patients.
Patients and Methods: Bone marrow samples were obtained from 80 patients with different hematologic malignancies. These consisted of 43 CML cases, 27 AML, 9 ALL and 1 MDS. In each case, cells were cultured and conventional cytogenetic analysis was performed.
Results: Among the 80 subjects, 53(66%) were abnormal and 27(34%) showed apparently normal karyotype. The various aberrations in abnormal cases were t(9;22)(q34;q11) in 43 CML (100%), Monosomy Y in 2 CML (4.6%), monosomy 7 in 1 CML (2.4%), trisomy 8 and t(15;17)(q22;q21) in 2 AML case(7.4%), t(8;21)(q22;q22) in 1 AML (3.7%) and complex karyotype in 2 CML, 1 AML , 1 ALL and 1 MDS (6%). Apart from these, some novel chromosomal abnormalities were observed in our study population.
Conclusion: The difference in the frequency of clonal chromosomal aberrations is probably the result of the applied methods for chromosome preparation and often very poor morphologic chromosome appearance, making the identification of finer structural abnormalities more difficult. Furthermore, ongoing cytogenetic studies are warranted in larger groups of hematologic malignancies to identify newly acquired chromosomal aberrations that may aid in cloning novel genes involved in the neoplastic process, ultimately helping in the development of targeted therapeutic drugs.
Sandberg AA. The Chromosomes in Human Cancer and Leukemia. 2nd ed. New York: Elsevier; 1990.
Heim S & Mitelman F. Cancer Cytogenetics. 2nd ed. New York: Wiley-Liss; 1995.
Dal Cin P, Morton CC. Metaphase Harvest and Cytogenetic Analysis of Malignant Hematological Specimens; Brigham and Women's Hospital, Boston, Massachusetts Current Protocols in Human Genetics 2003.
Dalcin PS & Morton CC. Cytogenetic for the Hematologists. In RI Handin, SE Lux & TP Stossel editors. Blood: Principles and Practice of Hematology. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.
Faguet BG. Hematologic Malignancies, Methods and Techniques. 2nd ed. New Jersey NJ: Humana Press; 2001.
Macleod RF & Drexler HG. Cytogenetic Analysis of Cell Lines. In CD Helgason & CL Miller editor. Basic Cell Culture Protocols, New Jersy NJ: Humana Press; 2005.
Christine J. Harrison. Cytogenetics of Pediatric and Adolescent Acute Lymphoblastic Leukaemia, British Journal of Haematology, 2009;. 144(2): 147-156.
Betsy H, Rosalie M, Diane A. Sequential G- to R-banding for High Resolution Chromosome Analysis, Human Genet, 1987; 76(1): 37-39. DOI:10.1007/BF00283047
Rodriguez-Revenga L, Badenas C, Sanchez A, et al. Cryptic Chromosomal Rearrangement Screening in 30 Patients with Mental Retardation and Dysmorphic Features; Clinical Genetics, 2004; 65(1): 17-23. DOI: 10.1111/j..2004.00167.
Pidersen B. MDS and AML with Trisomy 8 as the Sole Chromosome Aberration Show Different Sex Ratios and Prognostic Profiles: a Study of 115 Published Cases. American Journal of Hematology, 1997; 56(4): 224-229.
Grimwade D, Walker H, Harrison G, et al. The Predictive Value of Hierarchical Cytogenetic Classification in Older Adults with Acute Myeloid Leukemia (AML): Analysis of 1065 Patients Entered into the United Kingdom Medical Research Council AML 11 Trial. Blood 2001; 98:1312–20.
Fenaux P, Preudhomme C, Lai JL, et al. Cytogenetics and their Prognostic Value in de novo Acute Myeloid Leukemia: A Report on 283 cases. Br J Haematol, 1989; 73: 61–67.
Grimwade D, Walker H, Oliver F, et al. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered into the RMCAML10 Trial. Blood, 1998; 92: 2322–2333.
Yunis JJ, Lobell M, Arnesen MA, et al. Refined Chromosome Study Helps Define Prognostic Subgroups in most Patients with Primary Myelodysplastic Syndrome and Acute Myelogenous Leukemia. Br J Haematol, 1988; 68: 189–194.
Had N, Chadli B, Bousfiha A, et al. Cytogenetic Survey of 53 Moroccan Patients with Acute Myeloblastic Leukemia. Cancer Genet Cytogenet, 1996; 86: 124–128.
Tien HF, Wang CH, Lin MT, et al. Correlation of Cytogenetic Results with Immunophenotype, Genotype, Clinical Features, and Ras Mutation in Acute Myeloid Leukemia: a Study of 235 Chinese Patients in Taiwan. Cancer Genet Cytogenet, 1995; 84: 60–68.
| Files | ||
| Issue | Vol 3, No 3 (2009) | |
| Section | Articles | |
| Keywords | ||
| Chromosomal aberration Hematologic Malignancy Karyotype | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
